Green tea (Camellia sinensis)
Abstract and key points
- Green tea is derived from the shrubs Camellia sinensis through a non-fermenting process.
- The evidence for an association between green tea consumption and the incidence of cancer is generally inconsistent.
- Drinking green tea appears safe at regular, habitual and moderate use.
Green tea is derived from the shrub Camellia sinensis, the same plant as used for black tea, but is not fermented.
A total of 27 systematic reviews and/or meta-analyses investigated the association between green tea consumption and the risk of cancer. In general, inverse associations for green tea consumption and risk of gastrointestinal tract, oesophageal (women), lung (non-smoking women), ovarian, prostate and breast cancer were found. Evidence for a protective role of tea intake on the development of cancers of liver, colorectum, pancreas, urinary tract, prostate, glioma, lymphoma, and leukaemia was, however, insufficient.
Drinking green tea appears safe at regular, habitual and moderate use (3-9 cups per day).
CitationJianping Liu, Xun Li , CAM-Cancer Consortium. Green tea (Camellia sinensis) [online document]. http://cam-cancer.org/The-Summaries/Herbal-products/Green-tea-Camellia-sinensis. February 13, 2014.
Summary last updated and revised in February 2014 by Jianping Liu and Xun Li.
Summary fully updated and revised in May 2012 by Jianping Liu and Xun Li.
Summary fully updated and revised in April 2012 by Jianping Liu and Xun Li.
Summary first published in September 2005, authored by Jianping Liu.
- History of green tea [Website], accessed 28.12.13
- Green tea. Retrieved Feb. 25, 2012, from Wikipedia [Website], accessed 28.12.13
- Tanaka T, Ishii T, Mizuno D, et al. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68. Free Radical Biology and Medicine 2011, 50(10):1324-1335.
- Yuan JM, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmarcology research 2011, 64(2):123-135.
- Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005004. DOI:10.1002/14651858.CD005004.pub2.
- Sturgeon JL, Williams M, van Servellen G. Efficacy of green tea in the prevention of cancers. Nurs Health Sci. 2009 Dec;11(4):436-46. doi: 10.1111/j.1442-2018.2009.00476.x.
- Liu J, Xing J, Fei Y. Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies. Chin Med. 2008 Oct 22;3:12.
- Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2009; 65: 274-83.
- Fritz H, Seely D, Kennedy DA, Fernandes R, Cooley K, Fergusson D. Green tea and lung cancer: a systematic review. Integrative cancer therapies. 2013;12(1):7-24. Epub 2012/04/26.
- Wang Y, Yu X, Wu Y, Zhang D. Coffee and tea consumption and risk of lung cancer: a dose-response analysis of observational studies. Lung cancer (Amsterdam, Netherlands). 2012;78(2):169-70. Epub 2012/09/12.
- Zheng P, Zheng HM, Deng XM, Zhang YD. Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies. BMC gastroenterology. 2012;12:165.
- Sang LX, Chang B, Li XH, Jiang M. Green tea consumption and risk of esophageal cancer: a meta-analysis of published epidemiological studies. Nutrition and cancer. 2013;65(6):802-12. Epub 2013/08/06.
- Zheng JS, Yang J, Fu YQ, Huang T, Huang YJ, Li D. Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. Nutrition and cancer. 2013;65(1):1-16. Epub 2013/02/02.
- Hou IC, Amarnani S, Chong MT, Bishayee A. Green tea and the risk of gastric cancer: Epidemiological evidence. World journal of gastroenterology : WJG. 2013;19(24):3713-22. Epub 2013/07/11.
- Kang H., Rha SY, Oh KW, Nam CM. Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiology and Health 2010; 32:e2010001.
- Myung SK, Bae WK, Oh SM, Kim Y, Ju W, Sung J, Lee YJ, Ko JA, Song JI, Choi HJ. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2009; 124:670-7.
- Sasazuki S, Tamakoshi A, Matsuo K, Ito H, Wakai K, Nagata C, et al. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Japanese journal of clinical oncology. 2012;42(4):335-46. Epub 2012/03/01.
- Sing MF, Yang WS, Gao S, ect. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. European Journal of Cancer Prevention. 2011, 20(3):157-165.
- Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006; 27:1301-9.
- Wang XJ, Zeng XT, Duan XL, Zeng HC, Shen R, Zhou P. Association between green tea and colorectal cancer risk: a meta-analysis of 13 case-control studies. Asian Pacific journal of cancer prevention : APJCP. 2012;13(7):3123-7.
- Wang ZH, Gao QY, Fang JY. Green tea and incidence of colorectal cancer: evidence from prospective cohort studies. Nutrition and cancer. 2012;64(8):1143-52. Epub 2012/11/21.
- Wang X, Lin YW, Wang S, Wu J, Mao QQ, Zheng XY, et al. A meta-analysis of tea consumption and the risk of bladder cancer. Urologia internationalis. 2013;90(1):10-6. Epub 2012/10/12.
- Wu S, Li F, Huang X, Hua Q, Huang T, Liu Z, Liu Z, Zhang Z, Liao C, Chen Y, Shi Y, Zeng R, Feng M, Zhong X,Long Z, Tan W, Zhang X. The association of tea consumption with bladder cancer risk: a meta-analysis. Asia Pac J Clin Nutr. 2013;22(1):128-37. doi: 10.6133/apjcn.2013.22.1.15.
- Qin J, Xie B, Mao Q, Kong D, Lin Y, Zheng X. Tea consumption and risk of bladder cancer: a meta-analysis. World J Surg Oncol. 2012 Aug 25;10:172. doi: 10.1186/1477-7819-10-172.
- Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D. Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutrition and Cancer 2011; 63(5):663-672.
- Ogunleye AA, Xue F, Michels KB. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat. 2010; 119:477-484.
- Wu Y, Zhang D, Kang S. Black tea, green tea and risk of breast cancer: an update. SpringerPlus. 2013;2(1):240. Epub 2013/06/12.
- Trudel D, Labbe DP, Bairati I, Fradet V, Bazinet L, Tetu B. Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecologic oncology. 2012;126(3):491-8. Epub 2012/05/09.
- Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Molecular Nutrition & Food Research 2011; 55(6):931-940.
- Nagle CM, Olsen CM, Bain CJ, etc. Tea consumption and risk of ovarian cancer. Cancer Causes and Control 2010; 21(9):1485-1491.
- Brown MD. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern Med Rev 1999;4:360-70.
- Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009 Apr;65(4):331-41. doi: 10.1007/s00228-008-0610-7. Epub 2009 Feb 6.
- Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Cancer Res. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. 2006 Jan 15;66(2):1234-40.
- Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, Sokoloff MH, Gretzer MB, Chow HH. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res (Phila). 2012 Feb;5(2):290-8. doi: 10.1158/1940-6207.CAPR-11-0306. Epub 2011 Nov 1.
- Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgenindependent metastatic prostate carcinoma. Cancer. 2003 Mar 15;97(6):1442-6.
- Thomas F, Holly JM, Persad R, ect. Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells. Urology 2011; 78(2):421-475.
- Qiao J, Gu C, Shang W, ect. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food and Chemical Toxicology 2011; 49(6):1410-1415.
- Bannerman B, Xu L, Jones M et al. Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea. Cancer Chemother Pharmacol. 2011;68(5):1145-54.
- Golden EB, Lam PY, Kardosh A et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.Blood. 2009;113(23):5927-37.
- Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Low Dog T. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31(6):469-84.
The present documentation has been compiled by the CAM-CANCER Project with all due care and expert knowledge. However, the CAM-CANCER Project provides no assurance, guarantee or promise with regard to the correctness, accuracy, up-to-date status or completeness of the information it contains. This information is designed for health professionals. Readers are strongly advised to discuss the information with their physician. Accordingly, the CAM-CANCER Project shall not be liable for damage or loss caused because anyone relies on the information.